The COYOTE Study

The COYOTE Study

This study aims to find out if using an automated insulin delivery system can improve glucose levels in people with type 2 diabetes

GET INVOLVED

The COYOTE Study

The COYOTE Study

The COYOTE study aims to find out if using an automated insulin delivery system (also called a closed-loop system) can improve glucose levels in people with type 2 diabetes compared with standard insulin injections and a glucose sensor.

In this study, we want participants to trial a medical device for the management of type 2 diabetes called the CamHX system. If you agree to take part in this study you will commit to being involved for 6 months, attend hospital appointments, undertake training to learn how to use CamHX, complete hospital tests, diary entries and questionnaires. You will be required to attend St Vincent’s Hospital, Melbourne up to 5 times. Other study visits and contact will be conducted remotely.

To join this research study, you must:

Be aged 18 years or older

Have type 2 diabetes

Use insulin injections to manage your diabetes

Become a participant!
If you:

  • Are aged 18 years or older
  • Have type 2 diabetes
  • Use insulin injections to manage your diabetes

Then you may be a good match for this study

Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

Get involved

Please contact the Research Group Leader to discuss your options.

*All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne, as you will be required to attend regular clinical visits during your participation

    The COYOTE Study

    The COYOTE Study

    The COYOTE study aims to find out if using an automated insulin delivery system (also called a closed-loop system) can improve glucose levels in people with type 2 diabetes compared with standard insulin injections and a glucose sensor.

    In this study, we want participants to trial a medical device for the management of type 2 diabetes called the CamHX system. If you agree to take part in this study you will commit to being involved for 6 months, attend hospital appointments, undertake training to learn how to use CamHX, complete hospital tests, diary entries and questionnaires. You will be required to attend St Vincent’s Hospital, Melbourne up to 5 times. Other study visits and contact will be conducted remotely.

    To join this research study, you must:

    Be aged 18 years or older

    Have type 2 diabetes

    Use insulin injections to manage your diabetes

    Become a participant!
    If you:

    • Are aged 18 years or older
    • Have type 2 diabetes
    • Use insulin injections to manage your diabetes

    Then you may be a good match for this study

    Meet Kim Henshaw who is a participant in type 1 diabetes technology research at the DTRG. Watch Kim explain what it means to her to be a participant in this important area of research.

    Get involved

    Please contact the Research Group Leader to discuss your options.

    *All clinical trial participants must live within traveling distance of St Vincent’s Hospital Melbourne, as you will be required to attend regular clinical visits during your participation